Tamar Tchkonia

USPTO Granted Patents = 21 (Patent Applications = 15)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 125(Granted Patents)

Company Filing History:

21 out of 1,746

Mayo Foundation for Medical Education and Research

patents

16 out of 41

Unity Biotechnology, Inc.

patents

15 out of 49

Buck Institute for Research on Aging

patents

4. 4 out of 3,688

Johns Hopkins University

patents

5. 1 out of 1

Buck Institute for Research Aging

patent

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12226416 - Methods and materials for improving arteriovenous fistula maturation and maintaining arteriovenous fistula functionality (2025-02-18),

2. 11980616 - Treating liver disease by selectively eliminating senescent cells (2024-05-14),

3. 11925640 - Methods and materials for improving arteriovenous fistula maturation and maintaining arteriovenous fistula functionality (2024-03-12),

4. 11517572 - Killing senescent cells and treating senescence-associated conditions using a SRC inhibitor and a flavonoid (2022-12-06),

5. 11351167 - Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue (2022-06-07),

6. 10517866 - Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor (2019-12-31),

7. 10478433 - Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss (2019-11-19),

8. 10478432 - Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye (2019-11-19),

9. 10413542 - Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase (2019-09-17),

10. 10328073 - Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells (2019-06-25),

11. 10328058 - Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques (2019-06-25),

12. 10258618 - Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen (2019-04-16),

13. 10251376 - Increasing healthy lifespan and delaying progression of age-related phenotypes by selectively removing senescent cells (2019-04-09),

14. 10213426 - Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population (2019-02-26),

15. 10130628 - Treatment of joint pain (2018-11-20),

Title: The Innovative Journey of Tamar Tchkonia

Introduction: Tamar Tchkonia, a pioneering inventor based in Rochester, MN, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Tamar Tchkonia's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices for sustainable living.

Career Highlights: With a career spanning over two decades, Tamar Tchkonia has established herself as a leading figure in the tech industry, known for her inventive solutions to complex problems.

Collaborations: Throughout her career, Tamar Tchkonia has collaborated with top research institutions and universities to further her innovative projects, showcasing her dedication to pushing the boundaries of technology.

Conclusion: Tamar Tchkonia's relentless pursuit of innovation and her commitment to creating a more sustainable future through technology make her a true trailblazer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.